Povidone-iodine to stop Access related Infections and Transmission

Recruiting

18 years - 99 years

All

Phase 4

100 participants needed

1 Location

Brief description of study

Evaluating the impact of regular application of nasal povidone-iodine pre dialysis treatment on reducing rates of S. aureus ARBSI among hemodialysis patients.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: Staphylococcus aureus
Age: 18 years - 99 years
Gender: All

Receiving outpatient chronic hemodialysis, Male or Female, Age 18 or older,

Updated on 04 Aug 2024. Study ID: 834837

Find a site

Your Information has been sent successfully.

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.

Would you like to be notified about other trials? Sign up for Patient Notification Services.

Send a message

Enter your contact details to connect with study team

View email

Phone

View phone

Primary Contact

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Please provide your preferred way of contact

Race

Select race of your choice

Ethnicity

Select ethinicity

Are you Healthy Volunteer

Are you comfortable with the informed consent process?

Yes

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center

Povidone-iodine to stop Access related Infections and Transmission of Staphylococcus aureus (PAINTS)

Brief description of study

Eligibility of study

Find a site

Interested in the study